HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Köbel Selected Research

DNA (Deoxyribonucleic Acid)

1/2022DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.
1/2020Therapeutic options for mucinous ovarian carcinoma.
12/2016Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.
2/2016Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.
1/2014PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
4/2013Specimen quality evaluation in Canadian biobanks participating in the COEUR repository.
3/2013PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy.
1/2013Differentially methylated loci distinguish ovarian carcinoma histological types: evaluation of a DNA methylation assay in FFPE tissue.
6/2009Mutation of FOXL2 in granulosa-cell tumors of the ovary.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Köbel Research Topics

Disease

81Neoplasms (Cancer)
11/2023 - 03/2002
73Carcinoma (Carcinomatosis)
11/2023 - 03/2002
23Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 01/2008
22Endometrial Neoplasms (Endometrial Cancer)
06/2023 - 09/2008
20Endometrioid Carcinoma
01/2022 - 04/2006
10Ovarian Epithelial Carcinoma
11/2023 - 02/2010
8Adenocarcinoma
01/2022 - 01/2003
6Neoplasm Metastasis (Metastasis)
01/2022 - 04/2006
6Breast Neoplasms (Breast Cancer)
01/2021 - 06/2003
4Endometriosis
01/2023 - 05/2017
4Mucinous Adenocarcinoma (Mucinous Carcinoma)
11/2019 - 12/2009
3Turcot syndrome
11/2023 - 01/2020
3Disease Progression
01/2023 - 07/2014
3Sarcoma (Soft Tissue Sarcoma)
05/2021 - 08/2018
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 03/2013
3Ascites
05/2012 - 03/2002
2Carcinogenesis
02/2020 - 08/2008
2Residual Neoplasm
01/2020 - 04/2006
2Wilms Tumor (Wilm's Tumor)
01/2011 - 01/2009
1Neuroendocrine Carcinoma
07/2022
1Chromosomal Instability (Chromosome Stability)
01/2022
1Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3
03/2021
1Leiomyosarcoma
01/2021
1Endometrial Stromal Sarcoma
01/2021

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
11/2023 - 03/2002
30Biomarkers (Surrogate Marker)IBA
11/2023 - 11/2007
10Estrogen ReceptorsIBA
06/2023 - 06/2003
9Sucrose (Saccharose)IBA
01/2023 - 03/2016
9PlatinumIBA
11/2022 - 05/2012
9DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2009
7Exonucleases (3' 5' Exonuclease)IBA
01/2020 - 07/2014
7Progesterone Receptors (Progesterone Receptor)IBA
01/2020 - 10/2009
6Messenger RNA (mRNA)IBA
01/2023 - 03/2002
6ParaffinIBA
01/2023 - 04/2006
6Hormones (Hormone)IBA
06/2022 - 08/2013
6AntibodiesIBA
01/2022 - 03/2012
5MucinsIBA
01/2022 - 10/2011
5Eosine Yellowish-(YS) (Eosin)IBA
07/2020 - 04/2015
4Formaldehyde (Formol)FDA Link
01/2023 - 01/2013
4RNA (Ribonucleic Acid)IBA
11/2022 - 04/2013
4CytokinesIBA
01/2021 - 05/2003
4Hematoxylin (Haematoxylon)IBA
04/2018 - 04/2015
3Oral ContraceptivesIBA
01/2023 - 01/2009
3ChromatinIBA
01/2022 - 01/2018
3AntigensIBA
11/2020 - 01/2008
3Estrogens (Estrogen)FDA Link
01/2020 - 06/2016
3Carrier Proteins (Binding Protein)IBA
01/2019 - 03/2009
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2004 - 06/2003
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2004 - 03/2002
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2023 - 09/2005
2ProteomeIBA
12/2022 - 01/2019
2Phosphotransferases (Kinase)IBA
06/2022 - 01/2021
2taxaneIBA
04/2022 - 01/2021
2Cadherins (E-Cadherin)IBA
05/2021 - 07/2011
2Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 12/2009
2Androgen Receptors (Androgen Receptor)IBA
01/2021 - 01/2020
2Coloring Agents (Dyes)IBA
01/2021 - 07/2020
2Indicators and Reagents (Reagents)IBA
11/2020 - 08/2008
2podocalyxinIBA
11/2020 - 03/2012
2EnzymesIBA
11/2020 - 03/2002
2VimentinIBA
11/2019 - 11/2015
2Transcription Factors (Transcription Factor)IBA
01/2019 - 02/2010
2Fibronectins (Fibronectin)IBA
03/2012 - 01/2003
2Hepatocyte Nuclear FactorsIBA
01/2011 - 01/2009
2Insulin-Like PeptidesIBA
07/2010 - 03/2009
2Granzymes (Granzyme)IBA
07/2009 - 01/2008
2ezrinIBA
04/2006 - 04/2006
2TenascinIBA
01/2005 - 01/2003
2Protein Isoforms (Isoforms)IBA
11/2003 - 06/2003
2ProstaglandinsIBA
06/2003 - 03/2002
1Neurofibromin 1 (Neurofibromin)IBA
11/2023
1ORALIT (ORS)IBA
01/2023
1CyclinsIBA
01/2023
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2023
1GSK-J4IBA
01/2023
1purineIBA
12/2022
1LipidsIBA
12/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2022
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
06/2022
1SilverIBA
03/2022
1Letrozole (Femara)FDA LinkGeneric
01/2022
1Keratin-7 (Cytokeratin 7)IBA
05/2021
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
05/2021
1TropomyosinIBA
01/2021
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2021
1Immune Checkpoint ProteinsIBA
01/2021
1AndrogensIBA
01/2021
1DNA Polymerase IIIBA
01/2021
1Testosterone (Sustanon)FDA Link
01/2021
1ChemokinesIBA
01/2021

Therapy/Procedure

32Therapeutics
01/2023 - 05/2003
18Drug Therapy (Chemotherapy)
01/2023 - 08/2008
8Neoadjuvant Therapy
04/2022 - 07/2011
4Adjuvant Chemotherapy
01/2021 - 03/2009
3Immunotherapy
11/2020 - 01/2017
3Chemoradiotherapy
01/2020 - 03/2013
3Tubal Sterilization (Tubal Ligation)
05/2017 - 01/2009
2Precision Medicine
03/2022 - 11/2015
2Radiotherapy
01/2022 - 01/2021
1Mastectomy (Mammectomy)
01/2022